The feasibility study for pancreatic cancer screening by plasma biomarker using apoA2-isoforms.
Not Applicable
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-UMIN000028015
- Lead Sponsor
- IPPONMEDICALSCHOO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 15000
Inclusion Criteria
Not provided
Exclusion Criteria
1. The subjects underwent the pancreatectomy. 2. The subjects have undergone the treatmet for maligant disorders other than pancreatic cancer. 3. The subjects have the serious disorders, and 5-years survival cannot expect. 4. The subjects with the reasons which the medical institutions considered as inadequacy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ditection rate of the pancreatic cancer
- Secondary Outcome Measures
Name Time Method Detection rate and positive predictive value of the pancreatic disorders including pancreatic cancer. 2. Survival time and mortality.